Hello and Welcome to Patientsville.com, Your Source for all ELSPAR information. We are dedicated to provide You with ELSPAR safety information. Learn about ELSPAR serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ELSPAR Safety Reports
Total ELSPAR reports: 43.ELSPAR FDA safety alerts: No.
Reported deaths: 7 Reported hospitalizations: 11.
Take ELSPAR Side Effects Survey or Share Your ELSPAR Story. Read More Here.
Pharmacist from UNITED STATES reported ELSPAR problem on Jan 23, 2007. Male patient, weighting 184.0 lb, was diagnosed with t-cell lymphoma and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: erythema, hyperhidrosis, infusion related reaction. ELSPAR dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, CENTRUM, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, FLUCONAZOLE, FLUTICASONE PROPIONATE, GRANISETRON. Patient recovered.
ELSPAR problem was reported by a Physician from UNITED STATES on Feb 27, 2007. Male patient, 21 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: bacterial infection, disease progression, fungal infection, haemoptysis, mucosal inflammation, musculoskeletal disorder, pyelonephritis fungal, renal disorder, respiratory disorder. ELSPAR dosage: unknown. During the same period patient was treated with VINCRISTINE, DEXAMETHASONE. Patient recovered.
Consumer or non-health professional from JAPAN reported ELSPAR problem on Apr 10, 2007. Male patient, 25 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion, superior sagittal sinus thrombosis. ELSPAR dosage: unknown. During the same period patient was treated with CYTARABINE, METHOTREXATE. Patient recovered.
ELSPAR problem was reported by a Consumer or non-health professional from JAPAN on May 01, 2007. Male patient, 25 years of age, weighting 150.6 lb, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood bilirubin increased, brain oedema, cerebral haemorrhage, convulsion, hemiplegia, superior sagittal sinus thrombosis. ELSPAR dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, VINCRISTINE, CYCLOPHOSPHAMIDE, MITOXANTRONE, PREDNISOLONE, CYTARABINE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on May 15, 2007. Male patient, child 5 years of age, was diagnosed with t-cell lymphoma and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: fungal sepsis, hepatic steatosis, neutropenia, pancreatitis, perirenal haematoma, pneumonia, respiratory failure, retroperitoneal haemorrhage. ELSPAR dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN. Patient recovered.
ELSPAR problem was reported by a Health Professional from SPAIN on June 15, 2007. Female patient, child 11 years of age, weighting 110.2 lb, was diagnosed with granulocytopenia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: phlebitis, pyrexia. ELSPAR dosage: unknown. During the same period patient was treated with CANCIDAS, AMPHOTERICIN B, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported ELSPAR problem on June 17, 2007. Male patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion, hyperammonaemia, hypertriglyceridaemia, superior sagittal sinus thrombosis, transverse sinus thrombosis. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
ELSPAR problem was reported by a Health Professional from JAPAN on June 18, 2007. Male patient, child 11 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: pancreatic pseudocyst, pancreatitis acute. ELSPAR dosage: unknown. Patient recovered.
Physician from TURKEY reported ELSPAR problem on July 12, 2006. Male patient, child 3 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: ewing's sarcoma, metastasis. ELSPAR dosage: unknown. During the same period patient was treated with VINCRISTINE, CYTARABINE, METHOTREXATE, ETOPOSIDE, MERCAPTOPURINE. Patient recovered.
ELSPAR problem was reported by a Physician from TURKEY on July 12, 2006. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: metastasis, mucoepidermoid carcinoma. ELSPAR dosage: unknown. During the same period patient was treated with DACTINOMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, CYTARABINE, METHOTREXATE, ETOPOSIDE, MERCAPTOPURINE. Patient recovered.
Physician from TURKEY reported ELSPAR problem on July 12, 2006. Male patient, child 10 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: disease progression, primitive neuroectodermal tumour. ELSPAR dosage: unknown. During the same period patient was treated with DACTINOMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, CYTARABINE, METHOTREXATE, ETOPOSIDE, MERCAPTOPURINE. Patient died.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: soft tissue disorder. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion, soft tissue disorder. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, pneumonitis, sepsis. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, CYTARABINE, METHOTREXATE, MERCAPTOPURINE, ETOPOSIDE, CYCLOPHOSPHAMIDE, DAUNORUBICIN. Patient died.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: staphylococcal sepsis. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, CYTARABINE, METHOTREXATE, MERCAPTOPURINE, ETOPOSIDE, CYCLOPHOSPHAMIDE, DAUNORUBICIN. Patient died.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: enterobacter sepsis. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, CYTARABINE, METHOTREXATE, MERCAPTOPURINE, ETOPOSIDE, CYCLOPHOSPHAMIDE, DAUNORUBICIN. Patient died.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, CYTARABINE, METHOTREXATE, MERCAPTOPURINE, ETOPOSIDE, CYCLOPHOSPHAMIDE, DAUNORUBICIN. Patient died.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: soft tissue disorder. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: soft tissue disorder. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
ELSPAR problem was reported by a Physician from UNITED STATES on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, ETOPOSIDE, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on July 18, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion. ELSPAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
ELSPAR problem was reported by a Consumer or non-health professional from ISRAEL on July 14, 2006. Female patient, child 8 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: epistaxis, febrile neutropenia, fungal infection, mucous membrane disorder, nasal septum perforation, pulmonary mycosis. ELSPAR dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN, METHOTREXATE, TRIMETHOPRIM. Patient recovered.
Consumer or non-health professional from ISRAEL reported ELSPAR problem on July 14, 2006. Female patient, child 8 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: epistaxis, febrile neutropenia, fungal infection, mucous membrane disorder, nasal septum perforation, pulmonary mycosis, sinus disorder. ELSPAR dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN, METHOTREXATE, TRIMETHOPRIM. Patient recovered.
ELSPAR problem was reported by a Health Professional from JAPAN on Aug 09, 2006. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, haemorrhagic cerebral infarction, hypocoagulable state, intracranial venous sinus thrombosis. ELSPAR dosage: unknown. Patient recovered.
Health Professional from JAPAN reported ELSPAR problem on Aug 09, 2006. Male patient, 14 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: blood thrombin decreased, convulsion, depressed level of consciousness, gait disturbance, haemorrhagic cerebral infarction, hemiplegia, hypocoagulable state, leukaemia recurrent. ELSPAR dosage: unknown. Patient recovered.
ELSPAR problem was reported by a Health Professional from SPAIN on Aug 18, 2006. Male patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, coagulopathy, constipation, myelopathy, urinary incontinence. ELSPAR dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYTARABINE, HYDROCORTISONE, MERCAPTOPURINE. Patient recovered.
Health Professional from SPAIN reported ELSPAR problem on Sept 08, 2006. Male patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, coagulopathy, constipation, hemiparesis, myelopathy, neutropenia, paraplegia, urinary incontinence. ELSPAR dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYTARABINE, HYDROCORTISONE, MERCAPTOPURINE. Patient recovered.
ELSPAR problem was reported by a Pharmacist from BRAZIL on Nov 22, 2006. Male patient, 22 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient recovered.
Pharmacist from BRAZIL reported ELSPAR problem on Nov 22, 2006. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: intracranial venous sinus thrombosis. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient recovered.
ELSPAR problem was reported by a Pharmacist from BRAZIL on Nov 22, 2006. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient recovered.
Pharmacist from BRAZIL reported ELSPAR problem on Nov 20, 2006. Female patient, 46 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient was hospitalized. Patient died.
ELSPAR problem was reported by a Pharmacist from BRAZIL on Dec 05, 2006. Female patient, 46 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient was hospitalized. Patient died.
Pharmacist from BRAZIL reported ELSPAR problem on Dec 05, 2006. Male patient, 22 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: ischaemic cerebral infarction. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient recovered.
ELSPAR problem was reported by a Pharmacist from BRAZIL on Dec 05, 2006. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke. ELSPAR dosage: unknown. During the same period patient was treated with ANTHRACYCLINES, PREDNISONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ELSPAR problem on July 02, 2007. Male patient, weighting 192.5 lb, was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, dehydration, electrolyte imbalance, hepatic encephalopathy, mental status changes, weight decreased. ELSPAR dosage: 90120 MG. Patient was hospitalized. Patient recovered.
ELSPAR problem was reported by a Consumer or non-health professional from JAPAN on July 06, 2007. Male patient, child 11 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: pancreatic pseudocyst, pancreatitis acute. ELSPAR dosage: unknown. Patient recovered.
Physician from UNITED STATES reported ELSPAR problem on July 24, 2007. Female patient, 57 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: chills, fatigue, hepatic function abnormal, lung consolidation, lung neoplasm, neutropenia, opportunistic infection, pulmonary mass. ELSPAR dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE, PREDNISONE, IMATINIB MESYLATE. Patient was hospitalized. Patient recovered.
ELSPAR problem was reported by a Health Professional from POLAND on Aug 01, 2007. Female patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion, cyst, ischaemic stroke, pancreatic pseudocyst, pancreatitis, treatment failure. ELSPAR dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from POLAND reported ELSPAR problem on Aug 01, 2007. Female patient, child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, hepatomegaly, liver disorder, pancreatic pseudocyst, respiratory failure, transaminases increased. ELSPAR dosage: unknown. Patient was hospitalized. Patient recovered.
ELSPAR problem was reported by a Health Professional from SPAIN on June 15, 2007. Female patient, child 11 years of age, weighting 110.2 lb, was diagnosed with granulocytopenia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: phlebitis, pyrexia. ELSPAR dosage: unknown. During the same period patient was treated with CANCIDAS, AMPHOTERICIN B, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from POLAND reported ELSPAR problem on Aug 13, 2007. Female patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: convulsion, ischaemic stroke, pancreatic cyst, pancreatic pseudocyst, pancreatitis. ELSPAR dosage: unknown. Patient was hospitalized. Patient recovered.